A case is reported of a patient with recurrent acromegaly and otherwise normal pituitary function whose pituitary fossa was found to be completely empty at operation. She had previously been treated with external irradiation and trans-sphenoidal hypophysectomy. The location of her adenomato us and normal pituitary tissue has not been identified, but is presumed to be in or close to the wall of the sella turcica.
Case report
An Iranian woman, born in 1941, presented at her local hospital in 1961 in diabetic pre-coma following an acute onset of thirst and polyuria. She had no previous history or family history of diabetes mellitus. After initial treatment with insulin, she was later maintained on oral hypoglycaemic drugs and diet. In 1966 she was diagnosed at a London hospital as having acromegaly, at which time she complained of headaches, progressive enlargement of her hands and feet, and oligomenorrhoea for four years and amenorrhoea for six months. On direct questioning it seemed that some of her symptoms may have been present in 1961.
Clinical examination in 1966 revealed typical acromegalic appearance with normal visual fields and blood pressure of 110/60 mmHg. Investigations showed an enlarged pituitary fossa on skull X-ray, a high fasting plasma growth hormone concentration of 256 ng/ml (512 mufl), normal thyroid function.Tasting blood glucose of 162 mg/ml (9.0 mmol/l) and 2-hour value after glucose challenge of 251 mg/ml (13.9 mmol/l), raised fasting and peak plasma insulin levels of 158 and 166 Jlu/ml respectively, characteristic of diabetes associated with acromegaly. She received a Course of external deep X-ray therapy to the pituitary fossa (5000 rad) and her diabetes was Controlled with tolbutamide. After the radio-tCase presented to Clinical Section, 10 December 1982. Accepted 8 March 1983 0141-0768/83/110961-03/$01.00/0 therapy was completed, she returned to Iran and subsequently noted considerable improvement of her symptoms and acromegalic features. Her periods returned, following which she had two successful spontaneous pregnancies in 1970 and 1977 respectively.
She remained weIl and asymptomatic until 1979 when, because of recurrence of headaches, further enlargement of her hands and feet and worsening of diabetic control, she returned to London for further medical advice. Investigations confirmed recurrence of acromegaly. Plasma growth hormone concentrations before and two hours after glucose tolerance test were 170 and 180mull (normal < 10). Skull X-rays showed an enlarged pituitary fossa with asymmetrical downward extension of the floor to the right. Visual fields were normal. After her diabetes was controlled with insulin, a trans-sphenoidal hypophysectomy was carried out at Guy's Hospital in September 1979. At operation, the floor of the fossa was found to be penetrated by a pituitary tumour into the rightsphenoidal sinus. All visible tumour within and outside the fossa was carefully removed. Histological examination showed 'a pituitary eosinophil adenoma. Postoperatively, her fasting plasma glucose growth hormone fell to 30 mull but never returned to normal value.
There was little or no significant improvement in her acromegalic appearance. She was started on low-dose bromocriptine but could not even tolerate 1.25 mg daily because of vomiting.
By June 1980 her plasma growth hormone before and after glucose tolerance had risen to 48 and 65 mull respectively. Computerized tomographic scan and air encephalogram showed her pituitary fossa to be largely empty, with the possibility of some residual tissue. She was considered unsuitable for radioactive yttrium implantation at Hammersmith Hospital, but further operation to remove residual tumour was advised because she was again unable to tolerate bromocriptine. However, when her pituitary fossa was carefully re-explored in October 1981, it was found to be totally empty with no identifiable pituitary tissue.
By January 1982, her fasting plasma growth hormone had further risen to 88 mull but dynamic tests of all other pituitary function were normal. A repeat CT scan (Figure I) showed the empty sella but could not definitely locate the residual pituitary tissue. As the patient was unable to tolerate bromocriptine, she was started on metergoline, initially 2 mg daily followed by 4 mg daily. Her plasma growth hormone concentration fell from 70 to 43 mull within three hours of a test dose of metergoline 2 mg, and to 35 mull after 4 mg. Her headaches and galactorrhoea resolved and it was possible to withdraw insulin therapy and control her diabetes with glibenclamide and diet. It is proposed to increase the dose of metergoline gradually until her growth hormone concentration has fallen to within normal range, assuming no side effects occur.
Discussion
It is generally agreed that treatment of acromegaly should aim to reduce plasma growth hormone to normal levels and, whenever possible, to preserve the remaining pituitary function. In many patients, normalization of plasma growth hormone can be achieved and maintained following complete excision of the responsible pituitary adenoma by trans-sphenoidal hypophysectomy (Williams et al. 1975 , Hardy & Somma 1979 . However, in all large series, such as those of Williams et al. (1975) , Hardy & Somma (1979) and Laws et al. (1979) , a significant proportion of patients with acromegaly showed only partial or no significant improvement in growth hormone levels after the operation, implying incomplete removal of their pituitary adenoma. In our patient, the persistently raised, though improved, plasma growth hormone concentration following trans-sphenoidal hypophysectomy, coupled with otherwise normal pituitary function, clearly indicated that residual adenomato us as well as normal pituitary tissues were still present, but the pituitary fossa was found to be empty when it was re-explored surgically. The location of the residual pituitary tissues is unknown but is assumed to lie in the wall of the sella or outside it.
According to Hardy & Somma (1979) , the majority of pituitary tumours in acromegaly at the time of presentation can be classified as 'enclosed', i.e. the tumours have not breached the wall of the sella though they may expand it or extend above it. A small proportion is classified as 'invasive' and refers to those tumours which, though histologically benign, have penetrated through the bony wall of the sella, usually in a downward direction into the sphenoidal sinus. The degree of invasion may be localized or diffuse. In Hardy & Somma's series (1979) , of 120 patients with acromegaly treated by transsphenoidal hypophysectomy, the adenoma was 'enclosed' in 92 and 'invasive' in 28. In patients with an enclosed tumour, failure of growth hormone concentration to normalize after hypophysectomy assumes residual tumour cells in the cavity or possibly in the lining dura of the sella (Leavens et al. 1977) ; but in those with an invasive adenoma, residual tumour may be present inside the cavity, within the wall or outside the wall of the sella. Since none was found within the cavity of the sella in our patient, and the original tumour was known to be of the 'invasive' type at the time of her first operation, it is assumed that residual tissues probably lie within the wall of the sella or in the parasellar region. Their exact location has not been found and it may be that the residual tissue consists of diffuse or scattered islands of cells rather than a discrete nodule. Complete excision may therefore not be possible. Laws et al. (1979) reported two patients who had persistently raised growth hormone after trans-sphenoidal hypophysectomy; one was cured by craniotomy and removal of an extrasellar nodule, while the other had tumour tissue removed from the wall of the left cavernous sinus, without normalization of the plasma growth hormone concentration. Hardy & Somma (1979) commented that in their experience acromegalies with diffusely invasive pituitary adenomas are rarely cured despite extensive surgery, although postoperative radiotherapy may result in some additional clinical and biochemical improvement.
Postoperative radiotherapy was not possible in our patient since she had already received a full course when her acromegaly was first diagnosed. As she was unable to tolerate even small doses of bromocriptine, we tried her on metergoline with improvement of her symptoms and a modest fall of her growth hormone level. Metergoline is be. st known for its antiserotonin and antiprolactm action, but in doses of 4-8 mg daily it has also been found to reduce growth hormone as well as prolactin release in acromegalic patients (Deli tala et al. 1976 , Chiodini et al. 1976 , though the mode of action is not known. The drug has been used much less frequently in the UK than has bromocriptine, but it does represent an alternative method of reducing growth hormone in patients with acromegaly who, like our patient, are unable to tolerate bromocriptine and are not suitable for further surgery or radiotherapy. 
Amyloidosis in
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A patient with a 29-year history of Whipple's disease and associated arthritis is reported, in :-"hom rod-shaped organisms had been previous!y Identified in the synovial membrane as well as ..n the small intestine (Hawkins et al. 1976 ). Despt.te therapy, an intermittent inflammatory arthritis, Systemic symptoms and elevated acute phase P~oteins persisted. Further synovial and rect~1 bIopsies demonstrated the presence of amyloid deposits with characteristic congo red and thioflavine-T staining. The identification of~he material as amyloid was supported by specific ICase presented to Section of Rheumatology & Rehabilitation, 14-15 May 1982 . Accepted 9 March 1983 0141-Q768/83/110963-{)3/SOl.00/0 positive immunofluorescence to both the P and AA components. Electronmicroscopy of the synovial membrane demonstrated both intra-and extracellular masses of typical amyloid fibrils. This is the second case report of amyloidosis developing in Whipple's disease and the first to document it in the affected joints and gut.
Case report
A 59-year-old man was first seen in 1969 with a 16-year history of migratory arthritis of his large joints and a 6-month history of diarrhoea. weight loss, abdominal pain and pale offensive stools. Jejunal biopsy showed typical microscopic features of Whipple's disease, with short, broad and clubbed villi containing macrophages filled with PAS-positive material. Electron microscopy (EM) showed typical rod-shaped organisms. Treatment with tetracycline improved his joints. his weight increased and his abdominal symptoms disappeared. Over the next eleven years he required antibiotics, intra-articular and systemic steroids (2-5 mg prednisolone daily). his arthritis following a remitting course. For most of this time a raised ESR (22-35 mm/h) and raised C-reactive protein (CRP) (30-85 g/I) with a normochromic, normocytic anaemia (haemoglobin 10.0-12.8 g/dl) were noted. A synovial biopsy taken in 1975 showed rod-shaped organisms on EM (Hawkins et al. 1976) but no evidence of other articular disease or amyloid deposits. Antibiotic therapy was changed to erythromycin, and repeat synovial biopsies between 1975 and 1980 did not show any organisms. His antibiotic was stopped during this time.
In 1980 he developed cutaneous vasculitis with a purpuric rash and weight loss. No organisms were found on jejunal or synovial biopsy. A raised ESR (68-90 mm/h), CRP (80 g/I), IgA (7.8 g/l), circulating immune complexes and a thrombocythaemia (l 000000 X 10 9 f1) were noted. He had a good clinical response to high doses of steroids (30 rug/day) and erythromycin.
Further problems in 1981 were bronchopneumonia and hepatomegaly, the ESR and CRP remaining greatly elevated. There was also evidence of impaired renal function (blood urea 9.3 mol/l: creatinine clearance 61 ml/min), He was therefore investigated further and a rectal biopsy showed the presence of congo red staining material in the submucosa. Synovial biopsy showed extracellular material staining with congo red, with slight apple green birefringence under polarized light. Indirect immunofluorescence using monospecific antisera to tissue amyloid A protein and P-component showed specific extracellular reactivity ( Figure I) . Electronmicroscopy of the synovial membrane showed dense masses
